Issue 45 - The Cancer Letter

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Core Grants of Newer, Smaller Centers Slated to Get Immediate Funding Boost

NIH Looks For $1-2 Billion Raise in FY 2016, as Congress Approaches Another Deadline

The Academic Difference

ACS and ASCO Jointly Publish Breast Cancer Survivorship Guideline for Primary Physicians

In Brief

Rodriguez-Galindo to Lead St. Jude International Outreach

Daniel Simon named president of UH Case Medical Center

Terrill Jordan named president and CEO of Regional Cancer Care Associates

Gustave Roussy institute recruiting young doctors

Baylor to collaborate with Biocept on blood-based cancer tests

Drugs & Targets

FDA Approves Alecensa for ALK-Positive NSCLC Patients

FDA approves Vistogard for emergency treatment of certain chemotherapy overdoses

FDA clears cooling cap for preventing hair loss during chemotherapy

EMA grants orphan designation ot Debio 1143

Amgen submits expanded application for Kyprolis in the EU

AstraZeneca and Voluntis to test digital support service in ovarian cancer trials

Eli Lilly and Merck to collaborate on abemaciclib-Keytruda phase I trial

Recent Issues

Renew today!

Subscriber content

Login